II. Background
- Semisynthetic derivative of rifamycin
- Rifamycin produced by Streptomyces mediterranei
- Drug resistance emerges rapidly
- Must be used with other antituberculous drugs
III. Indications
- Multi-drug Tuberculosis Treatment regimen
IV. Contraindications
- Multiple Drug Interactions (especially lowering the serum levels of HIV Medications)
- Use only with caution with HIV Medications
V. Dosing
- Adult: 600 mg/day PO or IV
- Pediatric: 10-20 mg/kg/day (Max 600/day)
VI. Adverse Effects
- Nephritis or Acute Renal Failure
- Pruritus with or without Rash
- Thrombocytopenia and Hemolytic Anemia
-
Influenza-like Syndrome
- Associated with infrequent dosing
- Body fluids become orange tinged
- Urine
- Sweat
- Tears (may discolor Contact Lenses)
VII. Adverse Effects: Hepatotoxicity - Risk Factors
- Slow acetylators
- Hepatitis C
- Hepatitis B
- Concurrent Hepatotoxin exposure
- Age over 50 years
- Pregnancy and postpartum (within 3 months)
- Malnutrition
VIII. Drug Interactions: Increases other drug elimination, decreased levels and decreased efficacy (Strong CYP450 enzyme inducer)
-
Warfarin (Coumadin)
- Obtain INR weekly until stable and then for at least one month after stopping Rifampin
- Warfarin dose may need to increase up to 5x while on Rifampin
- (2014) Presc lett 21(8): 47
- Phenytoin (Dilantin)
-
Oral Contraceptives (as well as Contraceptive Patch, Estrogen Ring)
- Consider alternative contraceptives (e.g. Depo Provera, IUD)
- Antiretrovirals
- Ketoconazole
- Chloramphenicol
- Methadone
- Protease Inhibitors (reduced drug level and efficacy)
- Nonnucleoside reverse transcriptase inhibitors (reduced drug level and efficacy)
IX. Monitoring
- Complete Blood Count
- Baseline Liver Function Tests
- Follow labs if abnormal or Active Tuberculosis develops
Images: Related links to external sites (from Bing)
Related Studies (from Trip Database) Open in New Window
| rifampin (on 5/17/2017 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
| RIFAMPIN 150 MG CAPSULE | Generic | $1.10 each |
| RIFAMPIN 300 MG CAPSULE | Generic | $0.76 each |
Ontology: Rifampin (C0035608)
| Definition (CHV) | a kind of antibiotics |
| Definition (CHV) | a kind of antibiotics |
| Definition (NCI_NCI-GLOSS) | A drug used in the treatment of infections caused by bacteria. It belongs to the family of drugs called antibiotics. |
| Definition (NCI) | A semisynthetic derivative of rifamycin with broad antibacterial activity. Rifampin inhibits DNA-dependent RNA polymerase in susceptible bacteria and is often used in combination with other antibiotics for various infections including tuberculosis. |
| Definition (MSH) | A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) |
| Concepts | Antibiotic (T195) , Organic Chemical (T109) |
| MSH | D012293 |
| SnomedCT | 387159009, 29175007 |
| LNC | LP16274-0, MTHU008474 |
| English | Benemycin, Rifampicin, Rifamycin, 3-(((4-methyl-1-piperazinyl)imino)methyl)-, rifampin, Rifampin, rifampin (medication), RIFAMPIN, Rifampin [Chemical/Ingredient], rifampicin, Rifampicin product, Rifampin (product), Rifampin (substance), RIF |
| Swedish | Rifampin |
| Czech | rifampin, rifampicin |
| Finnish | Rifampisiini |
| Russian | RIFAMPIN, RIFAMPITSIN, RIFADIN, РИФАДИН, РИФАМПИН, РИФАМПИЦИН |
| Japanese | リマクタン, リファジン, リファンピン, アプテシン, リファンピシン |
| Italian | Rifampicina, Rifampina |
| Polish | Rifampicyna |
| Spanish | rifampicina (producto), rifampicina (sustancia), rifampicina, rifampina, Rifampicina, Rifampin |
| French | Rifampicine |
| German | Rifampicin, Rifampin |
| Portuguese | Rifampicina, Rifampina |
